OCM
CPRX

One Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

One Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.35M Buy
94,731
+19,758
+26% +$471K 0.06% 197
2025
Q4 		$1.75M Buy
74,973
+28,433
+61% +$633K 0.05% 225
2025
Q3 		$917K Buy
46,540
+19,751
+74% +$406K 0.03% 286
2025
Q2 		$581K Buy
+26,789
New +$632K 0.02% 348

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

One Capital Management's CPRX Position: Q1 2026 in Review

One Capital Management increased its Catalyst Pharmaceutical (CPRX) stake by 26% in Q1 2026, buying an estimated $471K and bringing the position to 94,731 shares worth $2.35M. The position accounts for 0.06% of the portfolio, ranked #197.

One Capital Management first reported a position in CPRX in Q2 2025 and has held it in 4 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • One Capital Management held 94,731 shares of Catalyst Pharmaceutical worth $2.35M as of Q1 2026.
  • One Capital Management bought 19,758 Catalyst Pharmaceutical shares in Q1 2026, an estimated $471K.
  • Catalyst Pharmaceutical made up 0.06% of One Capital Management's portfolio in Q1 2026, its #197 holding.
  • One Capital Management first reported a position in Catalyst Pharmaceutical in Q2 2025 and has held it in 4 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on One Capital Management's 13F filing for Q1 2026, filed 13 May 2026.